MedImmune Ventures
MedImmune Ventures invests in early to late stage, public and private biotechnology companies.
Business Model:
Revenue: $28.6M
Employees: 51-200
Rankings
Industries / Tags:
Detailed MedImmune Ventures Information
Geographic Data
Address: 1 Medimmune Way
City: Gaithersburg
State: MD
Zip: 20878
Country: US
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Twitter
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
MedImmune is a venture capital firm focuses on investing in pharmaceutical technology companies.
Contact Phone:
+13013983000
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 6/2009 | VaxInnate | Series D | 30M |
| 4/2004 | Inotek Pharmaceuticals | Series A | 20M |
| 5/2005 | Avidia | Series B | 28.5M |
| 9/2014 | VentiRx Pharmaceuticals | Series B | 50.6M |
| 11/2013 | Astria Therapeutics | Series B | 32.4M |
| 7/2012 | Cerapedics | Series C | 0 |
| 11/2012 | Ambit Biosciences | Venture Round | 0 |
| 6/2011 | Ambit Biosciences | Series D | 0 |
| 11/2007 | Ambit Biosciences | Series D | 49.3M |
| 1/2010 | VentiRx Pharmaceuticals | Series A | 25M |
| 1/2009 | Melinta Therapeutics | Series D | 0 |
| 5/2006 | Avidia | Series C | 43.8M |
| 10/2003 | Critical Therapeutics,Inc. | Series B | 56M |
| 8/2007 | Inotek Pharmaceuticals | Series C | 19.3M |
| 12/2011 | Astria Therapeutics | Series A | 8M |
| 6/2006 | VLST Corporation | Series B | 55M |
| 11/2003 | Applied Genetics Technologies Corporation | Venture Round | 27M |
| 4/2010 | Astria Therapeutics | Series A | 39M |
| 3/2004 | VaxInnate | Series B | 23.1M |
| 10/2006 | VaxInnate | Series C | 40M |
| 1/2007 | Sequoia Pharmaceuticals | Series C | 35M |
| 11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
| 6/2009 | Applied Genetics Technologies Corporation | Venture Round | 11.8M |
| 7/2012 | Coferon | Series B | 12M |
| 10/2013 | G1 Therapeutics | Series A | 0 |
| 2/2015 | G1 Therapeutics | Series B | 0 |
| 11/2005 | Inotek Pharmaceuticals | Series B | 35M |
| 9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
| 3/2008 | LigoCyte Pharmaceuticals | Series C | 29.5M |
| 7/2011 | Inotek Pharmaceuticals | Series D | 0 |
| 4/2005 | Receptor Biologix | Series A | 33.6M |
| 1/2009 | Hydra Biosciences | Series D | 22M |
| 7/2003 | Tercica | Series B | 44M |
| 11/2009 | Virdante Pharmaceuticals | Series A | 30M |
| 6/2010 | Corridor Pharmaceuticals | Series A | 0 |
| 10/2009 | Corridor Pharmaceuticals | Series A | 0 |
| 5/2016 | G1 Therapeutics | Series C | 0 |
| 9/2013 | Inotek Pharmaceuticals | Venture Round | 0 |
| 9/2004 | Cellective Therapeutics | Series A | 27.5M |
| 3/2008 | BrainCells | Series B | 30M |
| 10/2008 | Corridor Pharmaceuticals | Seed Round | 0 |
| 5/2002 | Panacea Pharmaceuticals | Series B | 3M |
| 3/2009 | NKT Therapeutics, Inc. | Series A | 8M |
| 2/2013 | Astria Therapeutics | Venture Round | 9M |
| 12/2010 | Astria Therapeutics | Series A | 14.5M |
| 8/2006 | Kemia | Series C | 0 |
| 1/2003 | Iomai Corporation | Series C | 54M |
| 10/2007 | Altiris Therapeutics | Series B | 0 |
| 5/2016 | G1 Therapeutics | Series C | 0 |
| 2/2015 | G1 Therapeutics | Series B | 0 |
| 9/2014 | VentiRx Pharmaceuticals | Series B | 0 |
| 11/2013 | Astria Therapeutics | Series B | 0 |
| 10/2013 | G1 Therapeutics | Series A | 0 |
| 9/2013 | Inotek Pharmaceuticals | Venture Round | 0 |
| 9/2013 | Inotek Pharmaceuticals | Debt Financing | 0 |
| 2/2013 | Astria Therapeutics | Venture Round | 0 |
| 11/2012 | Applied Genetics Technologies Corporation | Series B | 0 |
| 11/2012 | Ambit Biosciences | Venture Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
